These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11907099)

  • 1. Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells.
    Oberholzer A; Oberholzer C; Bahjat KS; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Abouhamze Z; Tsai V; LaFace D; Hutchins B; Moldawer LL; Clare-Salzler MJ
    J Immunol; 2002 Apr; 168(7):3412-8. PubMed ID: 11907099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.
    Oberholzer A; Oberholzer C; Efron PA; Scumpia PO; Uchida T; Bahjat K; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Tsai V; Hutchins B; Moldawer LL; Laface D; Clare-Salzler MJ
    Shock; 2005 Jun; 23(6):507-15. PubMed ID: 15897802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases.
    Oberholzer C; Tschoeke SK; Bahjat K; LaFace D; Hutchins B; Clare-Salzler MJ; Moldawer LL; Oberholzer A
    Scand J Immunol; 2005 Apr; 61(4):309-15. PubMed ID: 15853912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors.
    de Gruijl TD; Luykx-de Bakker SA; Tillman BW; van den Eertwegh AJ; Buter J; Lougheed SM; van der Bij GJ; Safer AM; Haisma HJ; Curiel DT; Scheper RJ; Pinedo HM; Gerritsen WR
    J Immunol; 2002 Nov; 169(9):5322-31. PubMed ID: 12391253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.
    Roth MD; Cheng Q; Harui A; Basak SK; Mitani K; Low TA; Kiertscher SM
    J Immunol; 2002 Oct; 169(8):4651-6. PubMed ID: 12370405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.
    Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU
    J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC.
    Tuettenberg A; Jonuleit H; Tüting T; Brück J; Biermann V; Kochanek S; Knop J; Enk AH
    J Immunol; 2004 Feb; 172(3):1524-30. PubMed ID: 14734730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
    Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
    J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells.
    Ozeri E; Mizrahi M; Shahaf G; Lewis EC
    J Immunol; 2012 Jul; 189(1):146-53. PubMed ID: 22634621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
    Hackstein H; Morelli AE; Larregina AT; Ganster RW; Papworth GD; Logar AJ; Watkins SC; Falo LD; Thomson AW
    J Immunol; 2001 Jun; 166(12):7053-62. PubMed ID: 11390449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability.
    Takayama T; Morelli AE; Onai N; Hirao M; Matsushima K; Tahara H; Thomson AW
    J Immunol; 2001 Jun; 166(12):7136-43. PubMed ID: 11390459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
    Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
    Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.
    de Gruijl TD; Ophorst OJ; Goudsmit J; Verhaagh S; Lougheed SM; Radosevic K; Havenga MJ; Scheper RJ
    J Immunol; 2006 Aug; 177(4):2208-15. PubMed ID: 16887980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
    Lee WC; Qiani S; Wan Y; Li W; Xing Z; Gauldie J; Fung JJ; Thomson AW; Lu L
    Immunology; 2000 Oct; 101(2):233-41. PubMed ID: 11012777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cells.
    Rea D; Laface D; Hutchins B; Kwappenberg K; Melief CJ; Hoeben RC; Offringa R
    Hum Immunol; 2004 Nov; 65(11):1344-55. PubMed ID: 15556685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo migration and survival of donor-derived dendritic cell progenitors genetically modified using an adenoviral vector encoding cDNA for TGF beta 1].
    Zhong C; Li WZ; Lü L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):174-7. PubMed ID: 11601033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.
    Commeren DL; Van Soest PL; Karimi K; Löwenberg B; Cornelissen JJ; Braakman E
    Immunology; 2003 Oct; 110(2):188-96. PubMed ID: 14511232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.